BRPI0410506A - tratamento de doenças mediadas por células t - Google Patents

tratamento de doenças mediadas por células t

Info

Publication number
BRPI0410506A
BRPI0410506A BRPI0410506-0A BRPI0410506A BRPI0410506A BR PI0410506 A BRPI0410506 A BR PI0410506A BR PI0410506 A BRPI0410506 A BR PI0410506A BR PI0410506 A BRPI0410506 A BR PI0410506A
Authority
BR
Brazil
Prior art keywords
diketopiperazines
mediated diseases
treatment
cell mediated
cell
Prior art date
Application number
BRPI0410506-0A
Other languages
English (en)
Inventor
David Bar-Or
Raphael Bar-Or
Richard Shimonkovitz
Original Assignee
Dmi Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dmi Biosciences Inc filed Critical Dmi Biosciences Inc
Priority claimed from PCT/US2004/015340 external-priority patent/WO2004103304A2/en
Publication of BRPI0410506A publication Critical patent/BRPI0410506A/pt

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"TRATAMENTO DE DOENçAS MEDIADAS POR CéLULAS T". A invenção fornece um método para o tratamento de doenças mediadas por células T e um método para a inibição da ativação de células T usando certas dicetopiperazinas; a invenção também se refere a composições compostas de certas dicetopiperazinas e a métodos para sintetizar dicetopiperazinas; a invenção fornece ainda métodos para se fazer composições farmacêuticas aprimoradas de proteínas e peptídeos para aumentar ou diminuir o conteúdo de dicetopiperazinas nas composições e as composições farmacêuticas aprimoradas resultantes.
BRPI0410506-0A 2003-05-15 2004-05-14 tratamento de doenças mediadas por células t BRPI0410506A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US47101803P 2003-05-15 2003-05-15
US48927003P 2003-07-21 2003-07-21
US51493003P 2003-10-27 2003-10-27
US51733803P 2003-11-04 2003-11-04
PCT/US2004/015340 WO2004103304A2 (en) 2003-05-15 2004-05-14 Treatment of t-cell mediated diseases

Publications (1)

Publication Number Publication Date
BRPI0410506A true BRPI0410506A (pt) 2006-06-20

Family

ID=36635909

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410506-0A BRPI0410506A (pt) 2003-05-15 2004-05-14 tratamento de doenças mediadas por células t

Country Status (1)

Country Link
BR (1) BRPI0410506A (pt)

Similar Documents

Publication Publication Date Title
WO2004103304A3 (en) Treatment of t-cell mediated diseases
DE60028970D1 (de) An her2 bindende peptidverbindungen
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
BR9914360A (pt) N-aralquilaminotetralinas como ligandos para oreceptor neuropeptìdeo yy5
WO2005049073A3 (en) Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
ATE362766T1 (de) Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen
WO2005019258A3 (en) Compositions and methods for the treatment of immune related diseases
NO20053077L (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
UA90657C2 (ru) Ловушки vegf и их терапевтические применения
MXPA06000660A (es) Uso de una composicion cosmetica o farmaceutica que comprende un extracto rico en lupeol, como un ingrediente activo para estimular la sintesis de proteinas de choque termico.
WO2004031129A3 (en) Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
DE602004016950D1 (de) Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung
ATE549353T1 (de) Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen
DE60137146D1 (de) Fusionszellen und zytokin-zusammensetzungen zur behandlung von krankheiten
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
WO2006029487A8 (en) Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis
WO2004043373A3 (en) Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
IL207012A (en) 28sgp medicinal product and 28sgp accent cancer treatment vaccine
WO2001007479A3 (en) Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases
BRPI0410506A (pt) tratamento de doenças mediadas por células t
WO2003059248A3 (en) Pigment epithelium derived factor from human plasma and methods of use thereof
DE60306503D1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
ATE448796T1 (de) Arzneimittel zur behandlung von tumoren und deren metastasen unter verwendung eines bindemoleküls gegen das bone-sialoprotein

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]